Xiamen Kingdomway Group Co
SZSE:002626
Xiamen Kingdomway Group Co
Revenue
Xiamen Kingdomway Group Co
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Xiamen Kingdomway Group Co
SZSE:002626
|
Revenue
¥3B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
2%
|
CAGR 10-Years
17%
|
|
C
|
CSPC Pharmaceutical Group Ltd
HKEX:1093
|
Revenue
¥31.5B
|
CAGR 3-Years
8%
|
CAGR 5-Years
12%
|
CAGR 10-Years
15%
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Revenue
¥10.1B
|
CAGR 3-Years
5%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Revenue
¥9.7B
|
CAGR 3-Years
14%
|
CAGR 5-Years
16%
|
CAGR 10-Years
22%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Revenue
¥22.3B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
7%
|
CAGR 10-Years
14%
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Revenue
¥39.1B
|
CAGR 3-Years
6%
|
CAGR 5-Years
8%
|
CAGR 10-Years
9%
|
See Also
What is Xiamen Kingdomway Group Co's Revenue?
Revenue
3B
CNY
Based on the financial report for Sep 30, 2023, Xiamen Kingdomway Group Co's Revenue amounts to 3B CNY.
What is Xiamen Kingdomway Group Co's Revenue growth rate?
Revenue CAGR 10Y
17%
Over the last year, the Revenue growth was -6%. The average annual Revenue growth rates for Xiamen Kingdomway Group Co have been -4% over the past three years , 2% over the past five years , and 17% over the past ten years .